Progression of Liver Pathology in Patients Undergoing the Fontan Procedure: Chronic Passive Congestion, Cardiac Cirrhosis, Hepatic Adenoma, and Hepatocellular Carcinoma

2006 ◽  
Vol 2006 ◽  
pp. 122
Author(s):  
T.P. Graham
Keyword(s):  
Hepatocellular Carcinoma ◽  
Fontan Procedure ◽  
Liver Pathology ◽  
Hepatic Adenoma ◽  
Cardiac Cirrhosis ◽  
Passive Congestion

scholarly journals Surgical Resection for Hepatocellular Carcinoma with Cardiac Cirrhosis after the Fontan Procedure

2016 ◽  
Vol 55 (22) ◽  
pp. 3265-3272 ◽  
Author(s):  
Yoshitaka Takuma ◽  
Yuji Fukada ◽  
Shota Iwadou ◽  
Hirokazu Miyatake ◽  
Shuji Uematsu ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Surgical Resection ◽  
Fontan Procedure ◽  
Cardiac Cirrhosis

Hepatic adenoma masquerading as a hepatocellular carcinoma in a patient with a Fontan procedure on the oral contraceptive pill

2021 ◽  
Vol 51 (4) ◽  
pp. 613-615
Author(s):  
Jessica V. Yao ◽  
Siddharth Sood ◽  
Julie Lokan ◽  
Anand Murugasu ◽  
Leeanne Grigg ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Oral Contraceptive ◽  
Fontan Procedure ◽  
Oral Contraceptive Pill ◽  
Hepatic Adenoma ◽  
Contraceptive Pill

Hepatocellular carcinoma in the adult Fontan patient

2016 ◽  
Vol 27 (2) ◽  
pp. 407-409 ◽  
Author(s):  
Michael R. Conroy ◽  
Tabitha G. Moe
Keyword(s):  
Heart Failure ◽  
Hepatocellular Carcinoma ◽  
Liver Biopsy ◽  
Liver Enzymes ◽  
Fontan Procedure ◽  
Tricuspid Atresia ◽  
Fontan Patient ◽  
Cardiac Cirrhosis ◽  
Fontan Patients ◽  
Carcinoma Hepatocellular

AbstractIn this study, we describe the case of a 36-year-old woman who was diagnosed with hepatocellular carcinoma on a background of Fontan procedure for tricuspid atresia. She had worsening heart failure in the months before presentation, and early investigations noted derangement in liver enzymes and hepatomegaly. Liver biopsy confirmed a hepatocellular carcinoma. Hepatocellular carcinoma is a rare but recognised consequence of cardiac cirrhosis in Fontan patients.

HEPATOCELLULAR CARCINOMA WITH CARDIAC CIRRHOSIS AFTER THE FONTAN PROCEDURE

2018 ◽  
Vol 41 (1) ◽  
pp. 68-71 ◽  
Author(s):  
Nuretdin Suna ◽  
Diğdem Özer Etik ◽  
Serkan Öcal ◽  
Fatih Hilmioğlu
Keyword(s):  
Hepatocellular Carcinoma ◽  
Fontan Procedure ◽  
Cardiac Cirrhosis

Fontan-Associated Liver Disease: Pathophysiology, Staging, and Management

2021 ◽  
Author(s):  
Luis Téllez ◽  
Enrique Rodríguez de Santiago ◽  
Agustín Albillos
Keyword(s):  
Hepatocellular Carcinoma ◽  
Portal Hypertension ◽  
Liver Disease ◽  
Fontan Procedure ◽  
Elevated Risk ◽  
Histological Changes ◽  
Global Management ◽  
Screening Strategies ◽  
History Of ◽  
Fontan Patients

AbstractFontan-associated liver disease is the term used to encompass the disorders arising from abnormal hemodynamic alterations and systemic venous congestion after the Fontan procedure. The histological changes produced in the liver are similar but not equivalent to those seen in other forms of cardiac liver disease. While the natural history of this form of liver disease is poorly established, many Fontan patients ultimately develop portal hypertension-related complications such as ascites, esophageal varices, malnutrition, and encephalopathy. Fontan survivors also show an elevated risk of hepatocellular carcinoma. Adequate staging of the liver damage is essential to anticipate screening strategies and improve global management.

Sign in / Sign up

Export Citation Format

Share Document